Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)

Organon

Status: Completed

Conditions: Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal

Treatments: Drug: Desloratadine Syrup

Study type: Observational

Funder types: Industry

Identifiers

NCT00761527

P05634

Details and patient eligibility

About

The purpose of this study is to observe the side effects of desloratadine syrup and how effective it is in relieving symptoms of allergic rhinitis or hives in Filipino children. The participants will take desloratadine syrup for 14 days. At the end of treatment, side effects will be recorded, as well as how the participants tolerate the medication. Effectiveness will also be rated at the end of treatment.

Full description

Physicians who commonly prescribed desloratadine treatment as standard care of treatment were selected enroll participants.

Enrollment: 2,980 patients

Sex: All

Ages: 6 months to 11 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatient pediatric participants, male or female, aged 6 months to 11 years
• Diagnosis of allergic rhinitis or chronic idiopathic urticaria

Exclusion criteria

• Known hypersensitivity to desloratadine

Trial design

2,980 participants in 1 patient group

Participants with allergic rhinitis or idiopathic urticaria

Description:

Outpatient pediatric participants (ages 6 months-11 years) in the Philippines with a diagnosis of allergic rhinitis or chronic idiopathic urticaria.

Treatment:

Drug: Desloratadine Syrup